<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92572">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02115854</url>
  </required_header>
  <id_info>
    <org_study_id>granuloma1</org_study_id>
    <nct_id>NCT02115854</nct_id>
  </id_info>
  <brief_title>Labial Biopsy in Patients With Tuberculosis Disease</brief_title>
  <official_title>The Value of Labial Biopsy in 65 Patients With Tuberculosis Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Lariboisière</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Lariboisière</source>
  <oversight_info>
    <authority>ANSM agence Nationale de sécurité du medicament : Paris,France</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The distinction between Tuberculosis disease (TB), a worldwide infective granulomatosis
      requiring long-term antibiotic treatment, and sarcoïdosis, a rare granulomatous disease
      successfully treated with high dose steroids is not straightforward and may delay the
      treatment choice by the physician.

      The goal was to evaluate prospectively and consecutively the presence of epithelioid
      granulomas in salivary glands biopsy of patients with TB.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>presence of granuloma on labial biopsy</measure>
    <time_frame>at day zero of treatment of tuberculosis</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">65</enrollment>
  <condition>Tuberculosis</condition>
  <condition>Sarcoidosis</condition>
  <arm_group>
    <arm_group_label>bacteriologically confirmed tuberculosis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>labial biopsy</intervention_name>
    <arm_group_label>bacteriologically confirmed tuberculosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        bacteriologically confirmed tuberculosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults above 18 years,

          -  bacteriologically confirmed tuberculosis

        Exclusion Criteria:

          -  patient not able to sign written consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Unite de Recherche Thérapeutique</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 15, 2014</lastchanged_date>
  <firstreceived_date>April 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hopital Lariboisière</investigator_affiliation>
    <investigator_full_name>Stephane Mouly, MD PhD</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sarcoidosis</mesh_term>
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
